Changing demographics of peptic ulcer disease O. Bonnevie Part 1: Peptic Ulcer Disease: Clinical Implications Pages: 8S - 14S
The pathophysiology of peptic ulcer disease F. P. Brooks Part 1: Peptic Ulcer Disease: Clinical Implications Pages: 15S - 29S
Current diagnosis and selection of patients for treatment of peptic ulcer disease R. Gugler Part 1: Peptic Ulcer Disease: Clinical Implications Pages: 30S - 35S
Anti-ulcer therapy A. Bettarello Part 1: Peptic Ulcer Disease: Clinical Implications Pages: 36S - 42S
Pharmacology of the treatment of peptic ulcer disease G. BertacciniG. Coruzzi Part 1: Peptic Ulcer Disease: Clinical Implications Pages: 43S - 51S
The surgical treatment of peptic ulcer disease J-P. Bader Part 1: Peptic Ulcer Disease: Clinical Implications Pages: 52S - 54S
Adherent and soluble mucus in the stomach and duodenum A. AllenN. J. H. Carroll Part 2: The Gastric Mucosal Barrier Pages: 55S - 62S
Gastroduodenal bicarbonate secretion in mucosal protection G. FlemströmE. KivilaaksoG. Jedstedt Part 2: The Gastric Mucosal Barrier Pages: 63S - 68S
The gastric mucosal barrier Gordon L. Kauffman Jr. Part 2: The Gastric Mucosal Barrier Pages: 69S - 76S
Gastric blood flow and the gastric mucosal barrier Eugene D. Jacobson Part 2: The Gastric Mucosal Barrier Pages: 77S - 80S
Overview of clinical cytoprotection Jon I. Isenberg Part 3: Role of Prostaglandins in Mucosal Cytoprotection in Health and Disease Pages: 81S - 82S
Prostaglandins and histological changes in the gastric mucosa Eric R. Lacy Part 3: Role of Prostaglandins in Mucosal Cytoprotection in Health and Disease Pages: 83S - 94S
Ultrastructural effects of ulcerogens Gregory L. Eastwood Part 3: Role of Prostaglandins in Mucosal Cytoprotection in Health and Disease Pages: 95S - 104S
Prostaglandins in pathophysiology of peptic ulcer disease S. J. Konturek Part 3: Role of Prostaglandins in Mucosal Cytoprotection in Health and Disease Pages: 105S - 108S
Prostaglandins as hormones N. ShimizuT. Nakamura Part 3: Role of Prostaglandins in Mucosal Cytoprotection in Health and Disease Pages: 109S - 113S
Chemistry and synthetic development of misoprostol P. W. CollinsR. PappoE. Z. Dajani Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 114S - 117S
Misoprostol preclinical pharmacology R. F. Bauer Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 118S - 125S
Metabolism and pharmacokinetic studies of misoprostol G. SchoenhardJ. OppermannF. E. Kohn Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 126S - 128S
Gastric morphology in ulcer patients receiving misoprostol Bernard M. Wagner Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 129S - 132S
Effect of misoprostol and cimetidine on gastric cell turnover A. FichN. ArberD. Rachmilewitz Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 133S - 135S
Misoprostol clinical pharmacology J. A. Steiner Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 136S - 141S
Preclinical toxicology profile of misoprostol F. N. KotsonisD. C. DoddF. E. Kohn Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 142S - 146S
Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers D. L. BrandW. M. RoufallE. J. Tapper Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 147S - 158S
Misoprostol in the treatment of duodenal ulcer S. J. SontagP. A. MazureE. Z. Dajani Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 159S - 163S
Healing of benign gastric ulcer N. M. AgrawalB. SaffouriE. Z. Dajani Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 164S - 170S
A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patients P. A. Nicholson Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 171S - 177S
Interim results of a multicenter international comparison of misoprostol and cimetidine in the treatment of out-patients with benign gastric ulcers M. J. Shield Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 178S - 184S
Overview of clinical safety with misoprostol R. L. HertingG. A. Clay Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 185S - 193S
Gastrointestinal cytoprotective effects of misoprostol Esam Z. DajaniCatherine H. Nissen Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 194S - 200S
Prostaglandins and chemotherapy-induced ulcers in dogs P. Bright-AsareI. GiannikopoulosJ. T. Whiten Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 201S - 203S
Summary F. P. BrooksG. Watkinson Part 4: Clinical and Pharmacological Actions of Misoprostol, a PGE1 Analog Pages: 204S - 205S